INTRODUCTION {#SEC1}
============

Alternative polyadenylation (APA) is a widespread phenomenon that generates transcript isoforms with different lengths of 3′ untranslated regions (3′UTR) by recognizing different polyadenylation signals (PASs) ([@B1]). More than 70% of human genes have multiple polyadenylation sites ([@B2]). As a common post-transcriptional modification mechanism, APA events may cause the alteration of important regulatory elements, such as miRNA binding sites and RNA protein binding sites, thus impacting the stability, localization and translation rate of mRNAs ([@B3]). APA modulation has been investigated in cells, tissues and different diseases. Previous studies have shown that APA often functions in a tissue- or cell-specific manner ([@B4],[@B5]), and several APA dysregulations have been identified in human diseases ([@B6]), including cancers ([@B10]). A significant global 3′UTR shortening has been found in cancer cell lines and tumor samples, compared with normal samples ([@B11]). Another study pointed out that shortening or lengthening of 3′UTR might lead to a worse prognosis in some cancers. For example, kidney cancer samples with the shorter isoforms *TMCO7* and *PLXDC2* were found to have lower survival rates ([@B12]). However, research on the APA role and APA regulation in cancer is still at an early stage.

As the most common genetic variant, single nucleotide polymorphisms (SNPs) are major contributors to the differences in human disease susceptibility ([@B13]). Genome-wide association studies (GWAS) have identified thousands of SNPs associated with complex traits and diseases. Currently, most studies of the disease/trait-related SNPs remain at statistical level, and the biological mechanism underlying them is still largely unknown ([@B14]). Quantitative trait locus (QTL) mapping, such as eQTL and meQTL analysis, is a method used to evaluate the effects of genetic variants on intermediate molecular phenotypes, and has been demonstrated as a powerful tool to decipher the function of SNPs and prioritize genetic variants within GWAS loci ([@B15]). Recent studies have confirmed the associations between several APA quantitative trait loci (apaQTLs) and cancer. For example, the presence of a SNP in a canonical PAS within *TP53* (AATAAA to AATACA) has been found to be highly associated with the processing of the impaired 3′ end of *TP53* transcripts and increase the susceptibility to cancers including cutaneous basal cell carcinoma, prostate cancer, glioma and colorectal adenoma ([@B20]). However, large-scale genome-wide analyses of apaQTL have rarely been reported, and no database for apaQTLs in cancer is available. Recently, Feng *et al.* have used Percentage of Distal polyA site Usage Index (PDUI) to quantify APA events for 10,537 tumor samples across TCGA 32 cancer types ([@B21]). Therefore, it is feasible to add APA as an additional dimension to the existing cancer genomic analysis.

In this study, by using the genotype and PDUI data, we developed a new computational pipeline to systematically perform apaQTL analyses across 32 cancer types. We further identified apaQTLs associated with patient overall survival time and apaQTLs located in GWAS linkage disequilibrium (LD) regions. The SNP2APA database (<http://gong_lab.hzau.edu.cn/SNP2APA/>) was constructed for browsing, searching and downloading the apaQTL data.

MATERIALS AND METHODS {#SEC2}
=====================

Collection and processing of genotype data {#SEC2-1}
------------------------------------------

We downloaded the genotype data across 32 cancer types from the TCGA data portal (<https://portal.gdc.cancer.gov/>) ([@B22]), which contained 898,620 SNPs called by Affymetrix SNP 6.0 array. We extracted 9082 samples with both genotype data and APA data available (Figure [1A](#F1){ref-type="fig"}). To increase the power for apaQTL discovery, IMPUTE2 was used to impute autosomal variants of all samples in each cancer type with haplotypes of 1000 Genomes Phase 3 as the reference panel ([@B23],[@B24]). After imputation, SNPs of each cancer type were selected in terms of the following criteria ([@B25]): (i) imputation confidence score, INFO ≥0.4, (ii) minor allele frequency (MAF) ≥5%, (iii) SNP missing rate \<5% for best-guessed genotypes at posterior probability ≥0.9 and (iv) Hardy-Weinberg equilibrium *P*-value \> 1 × 10^−6^ estimated by Hardy-Weinberg R package ([@B26]).

![Simplified schematic showing the workflow of SNP2APA database. (**A**) Collection of genotype and clinical data. (**B**) Collection of APA data and GWAS data. (**C**) Database content in SNP2APA. (**D**) The online PAS predict tool in SNP2APA. (**E**) Main functions in SNP2APA.](gkz793fig1){#F1}

Collection and processing of data for APA events {#SEC2-2}
------------------------------------------------

To quantify dynamic APA events, we used the PDUI value as the indicator and downloaded them from The TC3A Data Portal (<http://tc3a.org/>) for 32 cancer types (Figure [1B](#F1){ref-type="fig"}) ([@B21]). PDUI value was a novel, intuitive ratio for quantifying APA events based on RNA-Seq data ([@B12]). PDUI was calculated by the number of transcripts with distal polyA site divided by the total number of transcripts with both distal and proximal polyA sites. The greater PDUI represented the more transcripts using the distal polyA site, and vice versa. For example, value 1 indicated that all transcripts of the gene used the distal polyA site, while value 0 indicated that all transcripts of the gene used the proximal polyA site. For each cancer type, APA events were selected as follows: (i) the missing rate of PDUI data \<0.1, (ii) the standard deviation of PDUI \> 5%. After filtering, an average of 4143 APA events per cancer type were included for the further analyses. To minimize the effects of outliers on the regression scores, the PDUI values of each gene across all samples were transformed into a standard normal based on rank ([@B25]).

Obtaining of covariates {#SEC2-3}
-----------------------

To improve the sensitivity in QTL analyses, we collected several known and unknown confounders as covariates for apaQTL analysis ([@B25]). We first used the smartpca in the EIGENSTRAT program ([@B27]) to perform principal component analysis (PCA) of the genotype data for each cancer type. The top five principal components in genotype data were included as covariates for correcting the ethnicity differences. We additionally used PEER software ([@B28]) to analyse the APA data and obtained the first 15 PEER factors as covariates which were used for eliminating the possible batch effects and other confounders. Finally, other common confounders such as gender, age and tumor stage ([@B25],[@B29],[@B30]), were also included as covariates for apaQTL analysis.

Identification of *cis-* and *trans*-apaQTL using MatrixEQTL {#SEC2-4}
------------------------------------------------------------

For each cancer type, we evaluated pairwise associations between autosomal SNPs and APA events through linear regression by MatrixEQTL ([@B31]), a software for efficient QTL analysis. The SNP locations (hg19) were downloaded from dbSNP database (<https://www.ncbi.nlm.nih.gov/projects/SNP>) and distal PAS locations were extracted from the APA datasets. The SNPs with false discovery rates (FDRs) \<0.05 calculated by MatrixEQTL and the absolute value of correlation coefficient (*r*) ≥0.3 were defined as apaQTLs (Figure [1C](#F1){ref-type="fig"}). Of them, we further defined the apaQTLs within 1 Mb from the distal PAS as the *cis*-apaQTLs ([@B25]), while defined the apaQTLs beyond that region or on another chromosome as the *trans*-apaQTLs.

Identification of survival-associated apaQTLs {#SEC2-5}
---------------------------------------------

To prioritize promising apaQTLs, we further examined the association between apaQTLs and patient survival time. The clinical data including survival time of patient were downloaded from TCGA data portal. For each apaQTL, the samples were divided into three groups by genotypes: homozygous genotype (AA), heterozygous genotype (Aa), and homozygous genotype (aa). Then the log-rank test was performed to examine the differences in survival time, and Kaplan--Meier (KM) curves were plotted for intuitive visualization of the survival time for each group. Finally, apaQTLs with FDR \<0.05 were designated as survival-associated apaQTLs.

Identification of GWAS-associated apaQTLs {#SEC2-6}
-----------------------------------------

GWAS has been successfully used for identifying thousands of disease susceptibility loci, but it remains a challenge to pinpoint the causal variants and decipher their underlying mechanisms. To facilitate the interpretation of GWAS results, we integrated apaQTLs with the existing GWAS risk loci to explore trait/disease-associated apaQTLs. We downloaded all the risk tag SNPs identified in GWAS studies from GWAS catalog (<http://www.ebi.ac.uk/gwas>, accessed September 2018) ([@B32]). Then the SNPs in linkage disequilibrium (LD) regions with GWAS tag SNPs were extracted from SNAP (<https://personal.broadinstitute.org/plin/snap/ldsearch.php>) ([@B33]). The parameters were set as follows: (i) SNP dataset: 1000 Genomes, (ii) *r^2^* (the square of the Pearson correlation coefficient of LD) threshold: 0.5, (iii) population panel: CEU (Utah residents with northern and western European ancestry), (iv) distance limit: 500 kb. Finally, we defined apaQTLs that overlapped with these GWAS tag SNPs and LD SNPs as GWAS-associated apaQTLs.

DATABASE CONSTRUCTION AND CONTENT {#SEC3}
=================================

All results mentioned above were stored into MongoDB database (version 3.4.2) in the form of relation tables. A user-friendly web interface, SNP2APA (<http://gong_lab.hzau.edu.cn/SNP2APA/>), was constructed to support data browsing, searching, downloading and PAS online prediction (Figure [1D](#F1){ref-type="fig"} and [E](#F1){ref-type="fig"}), based on Flask (version 1.0.3) framework with Angularjs (version 1.6.1) as the JavaScript library. It was running on Apache2 web server (version 2.4.18). We have tested SNP2APA on various web browsers, including Chrome (recommended), Firefox, Opera, Internet Explorer, Windows Edge and Safari of macOS.

Data summary of SNP2APA {#SEC3-1}
-----------------------

In total, SNP2APA included 9082 tumor samples across 32 cancer types with both genotype data and APA data available for apaQTL analysis. The sample sizes for each cancer type ranged from 36 in cholangiocarcinoma (CHOL) to 1,091 in invasive breast carcinoma (BRCA) with a median of 221 (Table [1](#tbl1){ref-type="table"}). After genotype imputation and quality control, 4 390 660 SNPs on average per each cancer type were included for further analysis, ranging from 2 746 335 for BRCA to 5 143 663 for acute myeloid leukemia (LAML). After filtering APA events by both the rate of missing PDUI value \>0.1 and PDUI standard deviation \>0.05, we obtained an average of 4143 APA events per cancer type, ranging from 519 for thyroid carcinoma (THCA) to 6978 for stomach adenocarcinoma (STAD).

###### 

Summary of apaQTLs in SNP2APA

                                    *Cis*    *Trans*                         
  ------ ------- ----------- ------ -------- --------- -------- ------ ----- ------
  ACC    77      3 567 954   3114   3026     135       2864     1566   158   1422
  BLCA   408     4 190 525   3780   17 072   218       16 472   883    82    819
  BRCA   1 091   2 746 335   5379   11 941   212       11 376   501    7     470
  CESC   299     4 291 784   3268   14 767   211       14 358   773    114   745
  CHOL   36      4 012 152   3564   1 710    54        1610     1980   34    1153
  COAD   285     4 499 815   3356   15 797   231       15 264   1341   231   1280
  DLBC   48      4 845 461   3658   1630     67        1580     2640   126   2171
  ESCA   184     4 457 611   4510   27 484   615       26 009   665    122   644
  GBM    150     4 556 998   5353   36 614   801       34 381   575    126   539
  HNSC   518     4 254 665   4646   19 960   254       19 162   715    18    655
  KICH   66      3 771 774   4477   3047     136       3010     1477   128   1313
  KIRC   525     4 577 720   4906   20 978   240       19 596   905    25    867
  KIRP   290     4 895 360   4355   19 494   280       18 258   2390   330   2156
  LAML   122     5 143 663   3754   7675     159       7588     517    81    501
  LGG    515     4 634 138   5251   29 267   330       27 826   1150   41    1008
  LIHC   369     4 158 963   3127   10 779   159       10 511   842    131   738
  LUAD   511     4 384 429   4471   19 628   241       18 763   1210   23    1160
  LUSC   500     3 744 419   5126   21 804   296       20 915   718    14    673
  MESO   87      4 784 882   3999   9077     237       8447     1082   120   1019
  OV     291     2 963 431   6174   21 159   382       19 702   285    57    285
  PAAD   178     4 996 008   4466   20 351   462       19 177   1065   178   951
  PCPG   178     4 721 561   3696   25 042   571       23 185   1133   131   1130
  PRAD   494     4 828 721   4704   30 998   332       29 312   1842   15    1796
  SARC   258     4 088 267   3910   13 158   232       12 582   897    320   536
  SKCM   103     4 854 570   4179   12 811   310       11 672   1766   144   1702
  STAD   414     4 310 492   6978   23 045   334       21 499   478    97    465
  TGCT   150     4 825 013   4616   20 876   487       19 369   1118   204   1068
  THCA   503     4 877 853   519    2999     35        2896     10     9     9
  THYM   120     4 940 146   3773   12 939   325       12 255   971    117   957
  UCEC   176     4 950 486   2588   8903     288       8788     987    212   920
  UCS    56      3 888 385   3733   2206     99        1999     1185   143   1112
  UVM    80      4 737 552   3149   8021     186       7516     552    66    457

*cis*- and *trans*-apaQTLs in SNP2APA {#SEC3-2}
-------------------------------------

SNP2APA mainly provided four kinds of datasets: *cis*- and *trans*-apaQTLs, survival apaQTLs and GWAS-associated apaQTLs (Figure [2A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}). In the *cis*-apaQTL analysis, a total of 467 942 *cis*-apaQTLs across 32 cancer types were identified at the level of FDR \< 0.05 and \|*r*\| ≥ 0.3, with a median of 14 811 apaQTLs per cancer type, minimum of 1580 in lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), and maximum of 34 381 in glioblastoma multiforme (GBM). In the *trans*-apaQTL analysis, a total of 30 721 *trans*-apaQTLs across 32 cancer types were identified at *P*-value \< 1 × 10^−8^ and \|*r*\| ≥ 0.3, with a median of 936 apaQTLs per cancer type, minimum of nine in thyroid carcinoma (THCA), and maximum of 2171 in DLBC.

![The interface of SNP2APA database. (**A**) Browser bar in SNP2APA. (**B**) Modules of *cis*- and *trans*-apaQTL, survival apaQTL and GWAS apaQTL. (**C**) An example of survival apaQTL. KM-plot indicated that rs10247994 in KIRC was highly association with patient survival time, and box plot indicated that rs10247994 in KIRC was highly associated with PDUI values of the APA event in *PUSH* gene. (**D**) An example of GWAS apaQTL. Box plot indicated that GWAS associated apaQTL rs370151 in BRCA was highly associated with PDUI values of the APA event in *AMFR*. (**E**) Search results of *cis*-apaQTL dataset. (**F**) The heatmap displaying the correlation coefficient (*r*) of apaQTLs in the 'Pancan-apaQTL' page. The label for y-axis contains SNP ID, gene symbol of APA and APA event. (**G**) The input of online PAS prediction tool.](gkz793fig2){#F2}

Survival and GWAS associated apaQTLs {#SEC3-3}
------------------------------------

To prioritize promising apaQTLs, we associated apaQTLs with the survival data of patients downloaded from the TCGA portal. A total of 2154 apaQTLs associated with overall survival time across 32 cancer types at FDR \< 0.05, were identified and included in SNP2APA. For example, we found that rs10247994 was highly associated with patient overall survival time in kidney renal clear cell carcinoma (KIRC) (Figure [2C](#F2){ref-type="fig"}). The significant differences in PDUI values among corresponding genotypes of rs10247994 were observed, indicating that this SNP might play an important role in regulating the APA event of *PUSH* gene in KIRC (Figure [2C](#F2){ref-type="fig"}).

We further mapped apaQTL results to SNPs in GWAS regions and identified a total of 151 342 apaQTLs overlapping with GWAS LD regions with one or multiple traits. For example, rs2303282, as a risk SNP, was reported to be associated with BRCA ([@B34]). In our study, we found that rs370151 was in LD with the rs2303282 (LD *r*^2^ = 0.87) and was highly associated with APA event of *AMFR* gene. *AMFR* was reported to encode a tumor motor stimulating protein receptor ([@B35]). Thus, it could be inferred that rs370151 might play an important role in breast cancer by affecting APA events (Figure [2D](#F2){ref-type="fig"}).

THE FUNCTION AND USAGE OF SNP2APA DATABASE {#SEC4}
==========================================

SNP2APA provided a user-friendly web interface (<http://gong_lab.hzau.edu.cn/SNP2APA/>) that enabled users to browse, search, and download four datasets: *cis*-apaQTLs, *trans*-apaQTLs, survival-apaQTLs, and GWAS-apaQTLs. In addition, we designed a 'Pancan-apaQTL' page for batch search and visualization. A 'PAS Predict' page was constructed for online predicting whether a SNP could destroy or create the PAS of APA.

On the homepage, we provided a quick search option for users. After inputting an interested SNP, gene or APA event, users could obtain the corresponding results presented as four dynamic tables containing the information of *cis*-apaQTLs, *trans*-apaQTLs, survival-apaQTLs and GWAS-apaQTLs. By querying the *cis*/*trans*-apaQTL page, we could obtain a table containing the information of SNP ID, SNP genomic position, SNP alleles, APA events, gene symbol of APA, APA position, beta value (effect size of SNP on PDUI value), *r* value and *P*-value of apaQTL (Figure [2E](#F2){ref-type="fig"}). For each record, a vector diagram of the boxplot was embedded to display the association between SNP genotypes and PDUI values. By querying the survival-apaQTL page, the SNP ID, SNP genomic position, SNP alleles, sample size, log-rank test *P*-value, and median survival time of different genotypes will be displayed. For each record, a vector diagram of the KM-plot was provided for visualizing the association between SNP genotypes and overall survival time. On the 'GWAS-apaQTL' page, the information of the SNP, related APA event, gene symbol of APA and related traits would be available.

On the 'PanCan-apaQTL' page, users could submit multiple SNPs or gene symbols of APA events. Then they would obtain two heatmaps displaying the correlation coefficient (*r*) of *cis*-apaQTLs and *trans*-apaQTLs across the cancer types (Figure [2F](#F2){ref-type="fig"}).

PAS is the most important regulatory element during the regulation of APA events ([@B3]). To further explore the impact of SNP on PAS, we developed a web-based tool by utilizing Dragon PolyA Spotter (<http://www.cbrc.kaust.edu.sa/dps/Capture.html>) ([@B36]) and designed the 'PAS Predict' page. On this page, users could submit a wild-type sequence and the corresponding mutant sequence to predict the effect of SNP on polyadenylation signals (PAS) so as to determine whether SNP could destroy or create the PAS (Figure [2G](#F2){ref-type="fig"}).

In SNP2APA, four main datasets for each cancer type are freely available from the 'Download' page. The 'Help' page provided the basic information on database, pipeline of database construction, result summary, and contact. SNP2APA was open to any feedback with email address provided at the bottom of the 'Help' page.

CONCLUSION AND FUTURE DIRECTIONS {#SEC5}
================================

We developed SNP2APA as a resource providing comprehensive apaQTLs across 32 cancer types. To the best of our knowledge, this is the first database systematically evaluating the effects of the genetic variants on APA, especially in multiple cancer types with a large sample size. In recent years, increasing studies have suggested that APA is likely to play important roles in cancer. Therefore, it is urgent to add APA as an additional dimension to existing cancer genomic analysis. In this version of TC3A, by using genotype and APA data of 9082 tumor samples, we provided numerous apaQTLs among multiple cancer types and identified abundant apaQTLs associated with patient survival time or located in known GWAS loci. To explore the impact of SNPs on PAS, we also designed an online tool for users to predict functional apaQTLs. The SNP2APA database will greatly facilitate the interpretation of risk SNPs identified in genetic studies. In the future, with the increasing number of RNA-Seq datasets and genotype data from large consortium projects, we will continue to update the SNP2APA database. We believe that our database will be of particular interest to researchers in the field of genetic variants and APA in cancer.
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